Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$950k
6 rounds on record
Latest round
$950k
Convertible Note · Feb 2024 · 2 yr ago
Team
11-50
employees, estimated range
Grants
$9.5M
5 grants · CORDIS
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 1, 2025 Won a grant $3M · CORDIS Jul 1, 2024 Won a grant $298k · CORDIS Feb 21, 2024 Raised a round Convertible Note $950k · SEC Form D 2022 Founded Aug 1, 2021 Won a grant $4M · CORDIS Sep 17, 2018 Won a grant $1.9M · CORDIS Sep 21, 2017 Won a grant $300k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Jul 2025 $3M — CORDIS
Grant Jul 2024 $298k — CORDIS
Convertible Note Feb 2024 $950k — SEC Form D
Grant Aug 2021 $4M — CORDIS
Grant Sep 2018 $1.9M — CORDIS
Grant Sep 2017 $300k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity Focal Medical, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Michael AldridgeExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
BioSapienSeed $1.8M · 4 yr ago • 11-50 employees
BioSapien's MediChip™ delivers sustained cancer therapy directly at the tumor site while minimizing systemic exposure through localized…
uPATCHSeed · 23 mo ago
We offer microneedle applicators for Drug Delivery and Biosensing.
Continuity BiosciencesVenture round $8.4M · 14 mo ago • Founded 2023 • 1-10 employees
Continuity Biosciences builds adaptive combination products for precision therapeutic delivery — advancing oncology, cell therapy, and…
AlteromeVenture round $63.8M · 4 yr ago • Founded 2021 • 51-200 employees • 1 role
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and…
Accent is pioneering a new class of small molecule precision cancer therapies that target critical intracellular dependencies that span…
Actym TherapeuticsSeries A · this month • 51-200 employees
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…

Overview

Focal Medical is a clinical stage oncology company that has developed an energy-based drug delivery system for local and precise delivery of small molecules wit.

People

Michael Aldridge
Executive Officer, Director
Nessan Bermingham
Director
Jen Jen Yeh
Director
Joseph DeSimone
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Bradenton United States
HQ
10-50 est. staff

Financials

Total raised
$10.4M
Latest round
Grant
Funding rounds
6
Funding rounds
Round Announced Amount
Grant 2025 $3M Details
Grant 2024 $298k Details
Convertible Note 2024 $950k Details
Grant 2021 $4M Details
Grant 2018 $1.9M Details
Grant 2017 $300k Details